Target intelligence / Profile preview

Synaptosomal-associated protein 25 (SNAP-25) (SNAP-25)

Target
SNAP-25
Molecular classification
t-SNARE protein
01

Overview

Synaptosomal-associated protein 25 (SNAP-25) is a t-SNARE protein anchored to the plasma membrane via palmitoylated cysteines, contributing two α-helices to the four-helix bundle SNARE complex formed with syntaxin-1 and synaptobrevin/VAMP2. This complex drives synaptic vesicle docking, priming, and fusion for neurotransmitter release at synapses, regulated by calcium sensors like synaptotagmin and disassembled by NSF ATPase. SNAP-25 exists in isoforms SNAP-25A (embryonic) and SNAP-25B (adult neuronal), influencing processes beyond exocytosis such as spine density, neuronal plasticity, and metabolism. In disease, SNAP-25 mutations link to neurodevelopmental disorders, while botulinum neurotoxins (e.g., BoNT/A) cleave it to block release, serving as potent therapeutics for spasticity and cosmetics but risking paralysis. Emerging roles position SNAP-25 as a target for anesthetics like propofol, which disrupts its interactions, and as a biomarker for synaptic health in neurodegeneration.

Other names
SNAP25SNAP-25ASNAP-25BSUPSuper protein
02

Mechanism of action

Cleavage of SNAP-25 by botulinum neurotoxins inhibits SNARE complex formation and neurotransmitter release; Propofol disrupts Syntaxin1A/SNAP-25 interactions to impair exocytosis

03

Biological functions

Neurotransmitter releaseSynaptic vesicle docking and fusionSynaptogenesisNeuronal plasticitySpine morphogenesisPostsynaptic receptor trafficking
04

Disease associations

Neurodevelopmental disordersNeurodegenerative diseaseBotulism
05

Safety considerations

Botulinum neurotoxins cause prolonged paralysis due to dominant-negative cleavage of SNAP-25Risk of off-target inhibition of exocytosis leading to muscle weakness
06

Interacting drugs

Botulinum neurotoxin type A (BoNT/A)

2 more in the full profile.

07

Biomarkers

SNAP-25 levels as biomarker for neuronal integrity and synaptic function

Beyond the preview

Go deeper on Synaptosomal-associated protein 25 (SNAP-25) (SNAP-25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptosomal-associated protein 25 (SNAP-25) (SNAP-25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call